PM360

OCTOBER 28, 2022

Over the past decade, macro trends in healthcare have pushed life sciences companies to pursue increasingly sophisticated key account management (KAM) strategies and capabilities to provide unique offerings and value. How should leading pharma companies respond? Pharma Responds with Increasingly Complex KAM Strategies.

Key account management 117

Key account management Pharma Management Manufacturing 117

eMediWrite

AUGUST 26, 2022

The Nationwide Pharma Marketing Excellence Awards 2022 are designed to recognize individuals who have contributed to developing innovative pharmaceutical products and services that may aid in providing patients with top-notch healthcare. Nationwide Pharma Marketing Excellence Awards-Winners list for 2022.

Marketing 52

Marketing Pharma Key account management Management 52

European Pharmaceutical Review

JANUARY 24, 2023

This will help to maximise on cross-selling opportunities, providing a seamless and customer-centric experience to Velocity’s pharma and CRO partners. She has 20 years’ experience in business development and key account management in the clinical trials arena.

Key account management 98

Key account management Physicians Networking Management 98

pharmaphorum

DECEMBER 23, 2022

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). Given the demand to deliver a steady stream of content to meet HCPs’ needs, pharma marketers must react, create, edit, and adapt quickly. And in 2023, these investments will hopefully pay off.

Marketing 105

Marketing Sales Medical Patients 105

Star OUTiCO

FEBRUARY 1, 2022

I’ve worked in the pharmaceutical industry full-time for 24 years across a variety of roles but mostly within Leadership and Market Access, and latterly heading up Key Account Management at Boehringer-Ingelheim. Our pharma partners see this as one of the most valuable assets we have to offer.

Key account management 52

Key account management Medicine Marketing Management 52

Pharmaceutical Technology

MARCH 22, 2023

According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. In addition, in 2022, non-new molecular entity (NME) injectables approvals were the highest they have been for the last decade.

Pharma 52

Pharma Manufacturing Key account management Marketing 52